Safety and effectiveness of microemulsion cyclosporine in renal allograft recipients: 1-year follow-up study.
Park
K
K
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Kim
M S
MS
Kim
S I
SI
Kim
Y S
YS
Moon
J I
JI
D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D004304:Dosage Forms; D004655:Emulsions; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D011446:Prospective Studies; D015996:Survival Rate; D013997:Time Factors
D004304:Dosage Forms; D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine